Methods of treating a meiotic kinesinassociated disease

Details for Australian Patent Application No. 2009260527 (hide)

Owner Dana-Farber Cancer Institute Inc.

Inventors Pellman, David

Agent Davies Collison Cave

Pub. Number AU-A-2009260527

PCT Pub. Number WO2009/155025

Priority 61/057,590 30.05.08 US

Filing date 28 May 2009

Wipo publication date 23 December 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/155025 Priority application(s): WO2009/155025

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260528-Method and composition for a protein transduction technology and its applications

2009260526-Novel substituted indoles